ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/03/2026
Back to search
Official data from USPTO
ENTHYMIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/04/2026
Trademark type
Word
Nice classes
5
Filing date
02/28/2019
Registration date
03/10/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2020
Last transaction
06/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
OSAKA, JP
Examiner
AVENT, TEAGUE A
Law office
N80
Current location
TMO LAW OFFICE 126
Holders and representatives
Holders
SUMITOMO PHARMA CO., LTD.
SUMITOMO PHARMA SWITZERLAND GMBH
Enzyvant Therapeutics GmbH
Representatives
Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseasesdisorders and conditionsimmune deficiency related thereto; pharmaceutical preparations for human usetissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseasesdisorders and conditionsimmune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseasesdisorders and conditionsimmune deficiency related thereto; biologic preparations for medical and therapeutic purposestissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseasesdisorders and conditionsimmune deficiency related thereto
Publications
History of USPTO decisions and trademark events.
19 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/18/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2019
PUBO
PUBLISHED FOR OPPOSITION
12/24/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2019
ALIE
ASSIGNED TO LIE
11/20/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/16/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2019
DOCK
ASSIGNED TO EXAMINER
07/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/16/2019
GNRT
NON-FINAL ACTION E-MAILED
05/16/2019
CNRT
NON-FINAL ACTION WRITTEN
05/16/2019
DOCK
ASSIGNED TO EXAMINER
05/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/19/2019
NWAP
NEW APPLICATION ENTERED
03/04/2019
Continuous trademark protection
Get notified about every new filing that threatens ENTHYMIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.